BioAdaptives, Inc. Launches Xcellara™ Stem Cell Activator – Harnessing Nature for Optimal Health
December 10, 2024 09:15 ET
|
BioAdaptives Inc.
LAS VEGAS, Dec. 10, 2024 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives, Inc. (OTC: BDPT) is thrilled to announce the launch of Xcellara™ Stem Cell Activator, a groundbreaking supplement that harnesses...
BioAdaptives, Inc. Announces Institutional Review Board Approval of a Human Clinical Trial for Zeranovia™
November 25, 2024 09:15 ET
|
BioAdaptives Inc.
LAS VEGAS, Nov. 25, 2024 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives Inc. (OTC: BDPT) received approval today for a human clinical trial of its weight management product, Zeranovia™. The trial,...
BioAdaptives, Inc. Announces 5 Unique Products Ready for Phased Entry Into the Nutritional Marketplace
November 21, 2024 19:09 ET
|
BioAdaptives Inc.
LAS VEGAS, Nov. 21, 2024 (GLOBE NEWSWIRE) -- BioAdaptives Inc. (OTC: BDPT) ushered in a new direction by appointing James Keener as CEO on May 21, 2024. Previous management retired, and Keener began...
BioAdaptives, Inc. Announces Complete Product Overhaul with New Line of Scientifically Advanced Solutions
November 13, 2024 09:15 ET
|
BioAdaptives Inc.
LAS VEGAS, Nov. 13, 2024 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC: BDPT), a leading provider of innovative nutritional products, announces today a transformative shift in its product...
BioAdaptives, Inc. Letter to Shareholders Regarding the Reverse Stock Split
October 29, 2024 17:35 ET
|
BioAdaptives Inc.
LAS VEGAS, Oct. 29, 2024 (GLOBE NEWSWIRE) -- via IBN -- Due to a website maintenance error, a draft of a letter to BioAdaptives® (OTC: BDPT) shareholders was made available on the BioAdaptives®...
BioAdaptives, Inc. Welcomes Gimhana Dissanayake to Its Board of Directors
May 30, 2024 12:48 ET
|
BioAdaptives Inc.
We are confident that Gimhana’s leadership will significantly enrich our board’s talent and expertise, propelling us to new heights. LAS VEGAS, May 30, 2024 (GLOBE NEWSWIRE) -- via IBN --...